<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: MDRNA Sells Osteoporosis Drug</title>
	<atom:link href="http://www.xconomy.com/seattle/2009/04/01/mdrna-sells-osteoporosis-drug/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/seattle/2009/04/01/mdrna-sells-osteoporosis-drug/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 03:08:02 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Jimmy T</title>
		<link>http://www.xconomy.com/seattle/2009/04/01/mdrna-sells-osteoporosis-drug/comment-page-1/#comment-52848</link>
		<dc:creator>Jimmy T</dc:creator>
		<pubDate>Sun, 05 Apr 2009 14:49:32 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=18558#comment-52848</guid>
		<description>Mrna has been running low on cash alright, has high debt, lower sales growth, a high burn rate, and there is no improved earnings in sight. Several recent deals are much needed financial relief but the question remains &quot;how much longer can they continue like this and be a viable company, years from now?&quot;
Especially if shareholders are nor privy, to up front money amounts, after deals are made.
After all, this company is in a financial mess to say the least!</description>
		<content:encoded><![CDATA[<p>Mrna has been running low on cash alright, has high debt, lower sales growth, a high burn rate, and there is no improved earnings in sight. Several recent deals are much needed financial relief but the question remains “how much longer can they continue like this and be a viable company, years from now?”<br />
Especially if shareholders are nor privy, to up front money amounts, after deals are made.<br />
After all, this company is in a financial mess to say the least!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: News, Money and Drugs for Wednesday, April 1, 2009 (Pfizer-Wyeth Deal Scrapped!!!) &#124; IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Humor and Updates on the Latest Events in the Biotechnology and Pharmaceutical Industries</title>
		<link>http://www.xconomy.com/seattle/2009/04/01/mdrna-sells-osteoporosis-drug/comment-page-1/#comment-52559</link>
		<dc:creator>News, Money and Drugs for Wednesday, April 1, 2009 (Pfizer-Wyeth Deal Scrapped!!!) &#124; IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Humor and Updates on the Latest Events in the Biotechnology and Pharmaceutical Industries</dc:creator>
		<pubDate>Thu, 02 Apr 2009 00:06:49 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=18558#comment-52559</guid>
		<description>[...] Pharmaceuticals acquires rights to MDRNA osteoporosis drug and Nascobol from QOL. [Xconomy], [...]</description>
		<content:encoded><![CDATA[<p>[...] Pharmaceuticals acquires rights to MDRNA osteoporosis drug and Nascobol from QOL. [Xconomy], [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

